PCC SE is a Germany-based holding company of the PCC Group with a primary focus on the chemical industry and additional activities in energy and logistics. Through subsidiaries such as PCC Rokita SA, PCC Exol SA, and PCC MCAA Sp. z o.o., the group produces chlor-alkali products (e.g., chlorine, caustic soda), polyether polyols, surfactants and ethoxylates, polyethylene glycols, and monochloroacetic acid (MCAA). Its products supply sectors including personal and home care, detergents, plastics and construction, crop protection, pharmaceuticals, papermaking, and mining.
PCC SE operates an integrated value chain in Central Europe, with major production in Brzeg Dolny, Poland, and development projects in Lülsdorf, Germany. Integration includes upstream chlor-alkali and ethylene oxide streams feeding downstream specialties. The group invests in process modernization, emission reduction, and energy efficiency, supported by on-site utilities and growing renewable power assets. PCC SE’s strategy emphasizes expanding capacity in EO derivatives and MCAA while strengthening security of supply for internal and external customers.
Also known as PCC Group and PCC.
chemXplore tracks 6 projects involving PCC SE, of which 2 are active.
PCC SE's role on them: Owner, Investor / Financier, Operator, and Developer.
1 new construction and 1 expansion.
1 of the active projects carry no start-up date yet.
Offtakers are recorded on 1 of these 2 projects For subscribers
Targeting: Monochloroacetic acid (MCA) (1), Polyether polyol (1)
New flexible plant in Brzeg Dolny to produce non‑ionic surfactants, polyether polyols and ethoxylated compounds; completion targeted by end‑2028; investment ~PLN 842m.
Forecasts revenue near €1bn, EBITDA rising over 20% to a three‑digit million, and a return to EBIT profit; Q2 figures due Aug 20, 2026.
Antidumping probe targets Chinese imports of polyether polyols; provisional tariffs possible within 7 months, final measures in up to 14 months.
Share-swap would issue 4,251,619 new shares using a six‑month VWAP example (68.05 PLN), implying about €68m valuation; aims to centralise MCAA production and capture synergies.
Supervisory Board decision highlights long-term investor focus and leadership stability amid current market challenges.
EBITDA fell 2.9% to €13.0m while sales dropped 12% to €221.0m; EBT improved on exchange-rate effects; Trading & Services and logistics strengthened; bond repaid €21.0m.
New R&D hub with >5,000 m², 32 labs, 60+ research devices and Process Scaling Hall to accelerate lab-to-industry technology development.
Two measures — a €16m direct grant and up to €7m tax exemption — supported an ultra‑pure monochloroacetic acid plant in Brzeg Dolny; Commission found them compatible under regional aid rules.
